

1256. JAAPA. 2017 Jan;30(1):14-19. doi: 10.1097/01.JAA.0000510985.76167.ed.

HPV-associated oropharyngeal squamous cell carcinoma.

Smith TJ(1), Mendez A, Donald C, Nagel TH.

Author information: 
(1)Timothy J. Smith recently completed a PA fellowship in otolaryngology at the
Mayo Clinic in Phoenix, Ariz. Anthony Mendez is an instructor in the Department
of Otolaryngology and Head/Neck Surgery at the Mayo Clinic College of Medicine in
Phoenix and director of the PA fellowship in otolaryngology. Carrlene Donald
practices in the Department of Otolaryngology and Head/Neck Surgery at the Mayo
Clinic. Thomas Harold Nagel is an assistant professor in the Department of
Otolaryngology and Head/Neck Surgery at the Mayo Clinic. The authors have
disclosed no potential conflicts of interest, financial or otherwise.

Human papillomavirus (HPV) can infect the tonsillar tissues of the oropharynx and
is associated with oropharyngeal squamous cell carcinoma. This article provides
an overview to guide primary care providers in screening patients for
oropharyngeal cancer and making appropriate referrals. The article also reviews
available HPV vaccines and immunization adherence rates.

DOI: 10.1097/01.JAA.0000510985.76167.ed 
PMID: 27941569  [Indexed for MEDLINE]
